• Publications
  • Influence
Comparison of the effect of multiple short-duration with single long-duration exercise sessions on glucose homeostasis in type 2 diabetes mellitus
Aims/hypothesisWe evaluated and compared the effects on glycaemic control of two different exercise protocols in elderly men with type 2 diabetes mellitus.MethodsEighteen patients with type 2Expand
  • 65
  • 8
  • Open Access
Increased expression of TNF-alpha, IL-6, and IL-8 in HALS: implications for reduced adiponectin expression and plasma levels.
Human immunodeficiency virus (HIV)-associated lipodystrophy syndrome (HALS) is a side effect of highly active antiretroviral therapy of HIV-infected patients; however, the mechanism of theExpand
  • 169
  • 7
Soluble urokinase plasminogen activator receptor is a marker of dysmetabolism in HIV‐infected patients receiving highly active antiretroviral therapy
Circulating soluble urokinase plasminogen activator receptor (suPAR) reflects the immune and pro‐inflammatory status of the HIV‐infected patient. Highly active antiretroviral therapy (HAART)Expand
  • 96
  • 6
Cardiovascular risk prediction in the general population with use of suPAR, CRP, and Framingham Risk Score.
BACKGROUND The inflammatory biomarkers soluble urokinase plasminogen activator receptor (suPAR) and C-reactive protein (CRP) independently predict cardiovascular disease (CVD). The prognosticExpand
  • 88
  • 5
CRP and suPAR are differently related to anthropometry and subclinical organ damage.
BACKGROUND Low-grade inflammation is a marker for cardiovascular disease (CVD). The inflammatory biomarkers C-reactive protein (CRP) and soluble urokinase plasminogen activator receptor (suPAR)Expand
  • 68
  • 5
Mild hyponatremia carries a poor prognosis in community subjects.
OBJECTIVE Hyponatremia has been shown to predict adverse outcome in congestive heart failure and pneumonia among other common clinical entities, but its significance in the general population isExpand
  • 135
  • 3
Soluble urokinase plasminogen activator receptor is associated with subclinical organ damage and cardiovascular events.
OBJECTIVE The soluble urokinase plasminogen activator receptor (suPAR) is a plasma marker of low grade inflammation and has been associated with cardiovascular risk. We wanted to investigate whetherExpand
  • 64
  • 3
Regional anatomic differences in skeletal muscle mitochondrial respiration in type 2 diabetes and obesity.
CONTEXT Previous studies on leg skeletal musculature have demonstrated mitochondrial dysfunction associated with type 2 diabetes mellitus (T2DM), but it is not known whether mitochondrial dysfunctionExpand
  • 56
  • 3
Plasminogen activator inhibitor type 1 (PAI‐1) in plasma and adipose tissue in HIV‐associated lipodystrophy syndrome. Implications of adipokines
Background  PAI‐1, an important inhibitor of fibrinolysis, is increased in obese subjects and has been shown to be an independent risk factor for cardiovascular disease. In the present study, weExpand
  • 33
  • 3
Lipodystrophy in human immunodeficiency virus patients impairs insulin action and induces defects in beta-cell function.
The pathophysiology of insulin resistance in human immunodeficiency virus (HIV)-associated lipodystrophy syndrome (HALS) is not fully clarified. We investigated 18 men with HALS and 18 HIV-positiveExpand
  • 49
  • 2